-
-
-
-
-
-
-
Coherus Oncology Presents at SITC Clinical Multiomic Biomarker Data for CHS-114, a Highly Selective anti-CCR8 Cytolytic Antibody
-
-
-
-
-
-
-
Coherus Oncology to Report Second Quarter 2025 Financial Results on August 7, 2025
-
-
-
-
-
-
-
Coherus BioSciences (CHRS) Tops Q4 EPS by 2c
-
-
-
-
-
-
-
Coherus BioSciences (CHRS) Misses Q4 EPS by 50c, Misses on Revenue
-
-
-
-
-
-
-
Coherus BioSciences (CHRS) Tops Q2 EPS by 14c, beats revenue
-
-
-
-
-
-
-
Coherus BioSciences to Report Third Quarter 2022 Financial Results on November 8th, 2022
-
-
-
-
-
-
-
Coherus BioSciences to Report Fourth Quarter and Full Year 2021 Financial Results on February 17th, 2022
-
1,168,522 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

